The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Parque
Tecnológico de la Salud (PTS) / Universidad de Granada, in Granada, Spain, on November
24 and 25, 2022. This international conference has become an ideal forum for the early
drug discovery community, both from Academia and Industry. Every year we select a limited
number of topics with the idea of facilitating an “in-depth” discussion among professionals with very
different backgrounds. Still, all are focused on advancing the frontline of drug discovery and translational
medicine research.
This year, the programme will focus on four scientific areas that are continuously evolving and
increasingly having an impact on drug discovery:

  • Targeted Protein Degradation
  • Nucleic Acids as Therapeutic Agents
  • Antimicrobial Resistance and New Antibiotics
  • Biologics in DrugDiscovery and Development

We will also include a session to discuss

  • How to potentiateDrug Discovery in Spain?

 – The meeting is organized by the SDDN Association and Fundación MEDINA.
 – Scientific and Organizing Committee:   Olga Genilloud (Fundación MEDINA), Ana Martinez (CSIC), Emilio Díez (e10bio), Jorge Beleta
(SDDN), Marie-Hélène Larraufie (Almirall), Tamara Martinez (Sylentis), Domingo Gargallo (ABAC Therapeutics), Francesc Mitjans (Leitat), Julio Martin (Sciengement Lab Consulting), Jordi Quintana(Chemotargets). Gijs Jochems (Promega)